| A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers KN Kodumudi, K Woan, DL Gilvary, E Sahakian, S Wei, JY Djeu Clinical cancer research 16 (18), 4583-4594, 2010 | 570 | 2010 |
| Neutralization of tumor acidity improves antitumor responses to immunotherapy S Pilon-Thomas, KN Kodumudi, AE El-Kenawi, S Russell, AM Weber, ... Cancer research 76 (6), 1381-1390, 2016 | 555 | 2016 |
| Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions J Zhou, J Wu, X Chen, N Fortenbery, E Eksioglu, KN Kodumudi, ... International immunopharmacology 11 (7), 890-898, 2011 | 156 | 2011 |
| Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy A Basu, G Ramamoorthi, G Albert, C Gallen, A Beyer, C Snyder, G Koski, ... Frontiers in immunology 12, 669474, 2021 | 155 | 2021 |
| Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma KN Kodumudi, A Weber, AA Sarnaik, S Pilon-Thomas The Journal of Immunology 189 (11), 5147-5154, 2012 | 134 | 2012 |
| T-cells produce acidic niches in lymph nodes to suppress their own effector functions H Wu, V Estrella, M Beatty, D Abrahams, A El-Kenawi, S Russell, ... Nature communications 11 (1), 4113, 2020 | 102 | 2020 |
| Soluble CD14 and toll-like receptor-2 are potential salivary biomarkers for oral lichen planus and burning mouth syndrome M Srinivasan, KN Kodumudi, SL Zunt Clinical Immunology 126 (1), 31-37, 2008 | 102 | 2008 |
| Immunotherapy in breast cancer: Current status and future directions A Basu, G Ramamoorthi, Y Jia, J Faughn, D Wiener, S Awshah, ... Advances in cancer research 143, 295-349, 2019 | 97 | 2019 |
| Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma T Ghansah, N Vohra, K Kinney, A Weber, K Kodumudi, G Springett, ... Cancer Immunology, Immunotherapy 62, 1083-1091, 2013 | 90 | 2013 |
| Differential expression of TLR-2 and TLR-4 in the epithelial cells in oral lichen planus SB Janardhanam, S Prakasam, VT Swaminathan, KN Kodumudi, SL Zunt, ... Archives of oral biology 57 (5), 495-502, 2012 | 85 | 2012 |
| Intralesional injection of rose bengal induces a systemic tumor-specific immune response in murine models of melanoma and breast cancer P Toomey, K Kodumudi, A Weber, L Kuhn, E Moore, AA Sarnaik, ... PloS one 8 (7), e68561, 2013 | 78 | 2013 |
| Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model S Thirugnanam, P Pandiaraja, K Ramaswamy, V Murugan, ... Experimental parasitology 116 (4), 483-491, 2007 | 76 | 2007 |
| Immune checkpoint blockade to improve tumor infiltrating lymphocytes for adoptive cell therapy KN Kodumudi, J Siegel, AM Weber, E Scott, AA Sarnaik, S Pilon-Thomas PloS one 11 (4), e0153053, 2016 | 75 | 2016 |
| Intralesional rose bengal in melanoma elicits tumor immunity via activation of dendritic cells by the release of high mobility group box 1 H Liu, PP Innamarato, K Kodumudi, A Weber, S Nemoto, JL Robinson, ... Oncotarget 7 (25), 37893, 2016 | 58 | 2016 |
| A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds SB Anand, KN Kodumudi, MV Reddy, P Kaliraj Journal of helminthology 85 (4), 442-452, 2011 | 42 | 2011 |
| Immune response studies with Wuchereria bancrofti vespid allergen homologue (WbVAH) in human lymphatic filariasis SB Anand, M Gnanasekar, M Thangadurai, PR Prabhu, P Kaliraj, ... Parasitology research 101, 981-988, 2007 | 42 | 2007 |
| Sequential anti-PD1 therapy following dendritic cell vaccination improves survival in a HER2 mammary carcinoma model and identifies a critical role for CD4 T cells in mediating … KN Kodumudi, G Ramamoorthi, C Snyder, A Basu, Y Jia, S Awshah, ... Frontiers in immunology 10, 1939, 2019 | 41 | 2019 |
| Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer M Poch, ML Hall, A Joerger, K Kodumudi, M Beatty, PP Innamarato, ... Oncoimmunology 7 (9), e1476816, 2018 | 39 | 2018 |
| Suppression of colon inflammation by CD80 blockade: evaluation in two murine models of inflammatory bowel disease R Eri, KN Kodumudi, DJ Summerlin, M Srinivasan Inflammatory bowel diseases 14 (4), 458-470, 2008 | 39 | 2008 |
| Vaccine therapies for breast cancer EE Burke, K Kodumudi, G Ramamoorthi, BJ Czerniecki Surgical Oncology Clinics 28 (3), 353-367, 2019 | 38 | 2019 |
